Analyst Ratings for Progenics Pharmaceuticals (pgnx)

pgnx Rating Summary

pgnx Price Target Summary

* Over Last 12-Mos
  |   Expand Research on pgnx
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $10.80 (+25%) * Over Last 12-Mos
Rating Score: 7.1 / 10   Percentile Rank: 80%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
10/27/2016 Aegis Capital
» Updated 11/8/2016
New Coverage Buy
(N/A)
11.00
(N/A)
5.15 8.64 67.77% Details
10/4/2016 Brean Capital New Coverage Buy
(N/A)
11.00
(N/A)
6.77 8.64 27.62% Details
Like PGNX Ratings? Also take a look at VRX, SGEN, LXRX, ICPT

PGNX Ratings News